Eunice S. Wang, Pau Montesinos, Ghayas C. Issa, James M. Foran, Harry Paul Erba, Eduardo Rodríguez-Arbolí, Kateryna Fedorov, Maël Heiblig, Florian Heidel, Jessica K. Altman, Maria R. Baer, Lionel Adès, Kristen M. Pettit, Pierre Peterlin, Cristina Papayannidis, Zijing Zhang, Marcie Riches, Daniel Corum, Mollie Leoni, Amir Tahmasb Fathi. "Ziftomenib in relapsed/refractory (R/R)
            <i>NPM1</i>
            -mutant acute myeloid leukemia (AML): Phase 1b/2 clinical activity and safety results from the pivotal KOMET-001 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6506